Alpha 2.0
Login Register
» Authors » J Pelgrom

J Pelgrom

Explore the profile of J Pelgrom including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 28
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Microbiology
Top 10 Co-Authors
R Colebunders
F Van Wanzeele
N Clumeck
C Verhofstede
P Vermeir
E Florence
E Van Wijngaerden
E Van den Enden
A Mariman
S A Danner
Published In
Acta Clin Belg
Lancet
AIDS
AIDS Care
Arch Dermatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Determinants of adherence in a cohort of Belgian HIV patients: a pilot study
Degroote S, Vogelaers D, Vermeir P, Mariman A, De Rick A, Van Der Gucht B, et al.
Acta Clin Belg . 2014 Apr; 69(2):111-5. PMID: 24724750
Since the era of highly active antiretroviral therapy (HAART), HIV is considered a chronic disease. Adherence to HAART is crucial for effectiveness. Non-adherence negatively impacts patient outcome and the larger...
2.
Families affected by HIV: parents' and children's characteristics and disclosure to the children
Nostlinger C, Jonckheer T, de Belder E, Van Wijngaerden E, Wylock C, Pelgrom J, et al.
AIDS Care . 2004 Jun; 16(5):641-8. PMID: 15223533
The reduced risk of mother-to-child transmission due to improved HIV treatment has resulted in an increasing number of healthy children born to mothers living with HIV. The study's objective was...
3.
Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study)
Florence E, Dreezen C, Desmet P, Smets E, Fransen K, Vandercam B, et al.
Antivir Ther . 2002 Mar; 6(4):255-62. PMID: 11878407
Objectives: To compare the efficacy, tolerability and safety of a ritonavir 400 mg/saquinavir hard gel fomulation 400 mg twice daily versus an indinavir 800 mg once every 8 h containing...
4.
Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment
Colebunders R, Dohmen S, Van de Velde A, Pelgrom J, Hermans P
Acta Clin Belg . 2002 Jan; 56(5):321-2. PMID: 11770227
No abstract available.
5.
The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group
Gisolf E, Jurriaans S, Pelgrom J, Van Wanzeele F, van der Ende M, Brinkman K, et al.
AIDS . 2000 Apr; 14(4):405-13. PMID: 10770543
Objective: To evaluate the effect of treatment with ritonavir (RTV)/saquinavir (SQV)/6 stavudine (D4T) or RTV/SQV alone, with treatment intensification if needed, in protease inhibitor- and D4T-naïve HIV-1-infected individuals. Design: Multicentre,...
6.
The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues. Study of Protease Inhibitor Combinations in Europe
Moyle G, Pozniak A, Opravil M, Clumeck N, Delfraissy J, Johnson M, et al.
J Acquir Immune Defic Syndr . 2000 Mar; 23(2):128-37. PMID: 10737427
Objectives: To compare the efficacy and safety of saquinavir soft gelatin capsules (SQV-SGC) and nelfinavir (NFV), with or without two concomitant nucleoside reverse transcriptase inhibitors (NRTIs), in an exploratory objective...
7.
Cutaneous ulcer caused by Mycobacterium avium and recurrent genital herpes after highly active antiretroviral therapy
Pelgrom J, Bastian I, Van den Enden E, Portaels F, Colebunders R
Arch Dermatol . 2000 Jan; 136(1):129. PMID: 10632226
No abstract available.
8.
Euthanasia and physician-assisted suicide
Fleerackers Y, Colebunders R, Fonck K, Depraetere K, Pelgrom J
Lancet . 1996 Apr; 347(9007):1046. PMID: 8606587
No abstract available.